US Patent 10010533 Formulations of bendamustine
Patent 10010533 was granted and assigned to Eagle Pharmaceuticals, Inc. on July, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 14, 2017
Date of Patent
July 3, 2018
Patent Applicant
Patent Application Number
15432335
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10010533 Formulations of bendamustine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.